Based oncategory, theorganic analytical standardsegment is expected to witness the highest growth during the forecast period.

On the basis of category, the Analytical Standard Market is categorized into organic analytical standards and inorganic analytical standards. In 2016, the organic analytical standards segment accounted for the largest share.

It is also expected to register the highest CAGR during the forecast period.

- Advertising -

This can be attributed to increasing public-private investment for various research studies and increasing drug development activities & clinical trials.

Based ontechnique, thechromatographysegment is estimated to be the largest segment of the market in 2016.

On the basis of technique, the market is segmented into chromatography, spectroscopy, titrimetric, and physical properties testing. In 2016, the chromatography segment accounted for the largest share of the market, majorly due to the growing food safety concerns and increasing importance of chromatography tests in drug approvals.

Based on application, the environmental segment is estimated to have the largest share of the market in 2016.

Based on applications, the market is categorized into food & beverages, forensic, veterinary, petro chemistry, environmental, and pharmaceutical & life sciences. The environmental application segment accounted for the major share of the market owing to rising emissions of pollutants, regulatory mandates related to the environmental pollution control and rising awareness on the importance of a clean environment.

North America is expected to dominate the Analytical Standard Market in 2016.

Geographically, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America accounted for the largest share of the market in 2016, followed by Europe.

The market in North America is primarily driven by the availability of government funding for research and stringent regulations for pharmaceutical & biotechnology products. However, Asia-Pacific is expected to register the highest growth rate during the forecast period due to the outsourcing of clinical trials from developed to emerging Asian nations and increasing focus on soil testing and food security concerns in the region.